Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
WAYCEN Inc
Eastern Cooperative Oncology Group
Emory University
Boston Scientific Corporation
AstraZeneca
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Boehringer Ingelheim
AstraZeneca
AstraZeneca
National Cancer Institute (NCI)
Exelixis
AstraZeneca
Seattle Children's Hospital
Seattle Children's Hospital
Providence Health & Services
TScan Therapeutics, Inc.
AstraZeneca
M.D. Anderson Cancer Center
University of Kentucky
AstraZeneca
M.D. Anderson Cancer Center
Sichuan Baili Pharmaceutical Co., Ltd.
Washington University School of Medicine
Exelixis
Duke University
Nuvectis Pharma, Inc.
GlaxoSmithKline
Australasian Gastro-Intestinal Trials Group
Memorial Sloan Kettering Cancer Center
AstraZeneca
AstraZeneca
Laval University
Columbia University
Alliance for Clinical Trials in Oncology
Replimune Inc.
National Cancer Institute (NCI)
Providence Health & Services
University of Cologne
ShuGuang Hospital
R-Pharm
CARsgen Therapeutics Co., Ltd.